Today

Agents

Chat

Arena

Discover

More

App

Morgan Stanley cuts Bristol-Myers Squibb target price to $40 from $41

BMY•2026-10-30

Morgan Stanley cut its target price for Bristol-Myers Squibb to $40 from $41.

Related News

W

Nasdaq trade halt continues; reason unavailable at 03:58 a.m.

WFF•2026-10-30

AstraZeneca reaffirms 2026 outlook for low double-digit core EPS growth at constant exchange rates

AZN•2026-10-30

Nasdaq trade halt continues; reason not available at 03:58 a.m.

EFTY•2026-10-30

BOJ Governor Ueda's comments at news conference

TLT•2026-10-30

German import prices up 10.4% year on year in September

EWG•2026-10-30

Morgan Stanley cuts Bristol-Myers Squibb target price to $40 from $41 - BMY News | Rallies